Severe atopic dermatitis: Therapeutic update.

CW Kwon, LA Beck - Allergy & Asthma Proceedings, 2018 - search.ebscohost.com
Background: Atopic dermatitis (AD) is a common inflammatory skin disorder with a multitude
of highly characterized comorbidities that affect infants, children, and adults worldwide …

Changing perspectives in atopic dermatitis

E Serra-Baldrich, JO De Frutos, I Jáuregui… - Allergologia et …, 2018 - Elsevier
Atopic dermatitis (AD) is a multifaceted disease that involves a complex interplay between
the skin and the immune system. The course of the disease depends strongly on the genetic …

Atopic dermatitis biomarkers and the movement toward personalized treatment

S Hassan, N Hamideh, C Poulos, S Cheema… - Dermatitis, 2021 - liebertpub.com
Atopic dermatitis (AD) is a heterogeneous disorder with varying phenotypes. Although AD
has long been associated with barrier dysfunction, the pathogenesis of this disease is more …

Biologic therapy for atopic dermatitis: moving beyond the practice parameter and guidelines

M Boguniewicz - The Journal of Allergy and Clinical Immunology: In …, 2017 - Elsevier
Atopic dermatitis (AD), a common chronic pruritic inflammatory skin disease, impacts the
quality of life of patients and caregivers and has become a global health problem. It is …

[HTML][HTML] Clinical trials of antibody drugs in the treatments of atopic dermatitis

G Zhou, Y Huang, M Chu - Frontiers in Medicine, 2023 - frontiersin.org
Atopic dermatitis (AD) is one of the most common, relapsing, chronic inflammatory skin
disease, being regarded as a global health issue. Recent studies have shown that Th2 cell …

Atopic dermatitis: treatment and innovations in immunotherapy

F Ferrara, A Zovi, M Capuozzo, R Langella - Inflammopharmacology, 2024 - Springer
Atopic dermatitis (AD) is a common inflammatory skin disease characterized by itching and
skin barrier dysfunction. Moderate to severe AD is often refractory to first-line topical …

[HTML][HTML] Monoclonal antibody therapies for atopic dermatitis: where are we now in the spectrum of disease management?

JQ Del Rosso - The Journal of clinical and aesthetic dermatology, 2019 - ncbi.nlm.nih.gov
Atopic dermatitis (AD) is a chronic disorder that requires thorough patient education and a
therapeutic management strategy designed to control flares, decrease recurrences, and …

[HTML][HTML] Atopic dermatitis: striving for reliable biomarkers

S Mastraftsi, G Vrioni, M Bakakis, E Nicolaidou… - Journal of Clinical …, 2022 - mdpi.com
Atopic dermatitis (AD) is a highly heterogeneous inflammatory disease regarding both its
pathophysiology and clinical manifestations. However, it is treated according to the “one …

Systemic therapies for moderate-to-severe atopic dermatitis: expert perspectives in practice

M Lebwohl, AF Alexis, LA Beck, JK Block… - Journal of drugs in …, 2019 - europepmc.org
Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects around 13% of
children and 7% of adults in the US. It can have a significant impact on the quality of life …

[HTML][HTML] Biological treatments in atopic dermatitis

A Montes-Torres, M Llamas-Velasco… - Journal of clinical …, 2015 - mdpi.com
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases that
affect both children and adults with a prevalence of 30% and 10%, respectively. Even …